Term
|
Definition
-the concentration at which half the receptors have ligand bound
Kd=[L][R]/[LR] |
|
|
Term
Graded Dose Effect Relationships |
|
Definition
-the response to a drug is proportional to the concentrationof receptors that have drug bound to them
|
|
|
Term
|
Definition
-concentration at which a half-maximal effect is obtained
-a measure of potency
-EC50 may or may not equal Kd
|
|
|
Term
|
Definition
compounds that promote the conformational change to an active receptor |
|
|
Term
|
Definition
bind to the receptor but do not promote the conformational change |
|
|
Term
|
Definition
-activation of an opposing physiological mechanism to reduce an undesirable response or state
-ex) vasoconstrict nasal mucosa with psuedoephedrine to contract vasodilation caused by histamine
-compensatory pathway |
|
|
Term
Pharmacological antagonist |
|
Definition
interact directly with the target for the endogenous ligand |
|
|
Term
|
Definition
-binds reversibly to the active site but does not induce a conformational change
-increases EC50 therefore decrease the potency
-no effect on maximal efficacy
|
|
|
Term
Noncompetitive Antagonist |
|
Definition
-either binds irreversibly to active site or reversibly to an allostertic site
-decrease the efficacy
-EC50 does not change |
|
|
Term
|
Definition
-binds to agonist binding site, but even when the receptors are fully occupied, they have a lower efficacy
-full and partial agonists bind to the same site but with different efficacies
-therefore, a partial agonist will reduce the effect of a full agonist, appearing as a competitive antagonist
-rather than completely inhibiting the response to a full agonist, one will see a reduction to a level of activity equal to the efficacy of the partial agonist
-used as a competitive antagonist with a built-in safe margin so that an overdose will not completely reduce activity |
|
|
Term
|
Definition
-in some cases, a receptor can be active in the absence of an agonist
-acts by inhibiting this constitutive activity of the unoccupied receptor
-deactivates receptors that are active in the absence of agonists
-there will be situations where the antagonist will have no effect(bc there is not agonist at the receptor
-inverse agonist will have an effect (bc the receptor is constitutively turned on)
|
|
|
Term
|
Definition
-We assume that the max effect is seen when 100% of receptors are bound (this is not the case)
-the maximal effect is obtained at a lower dose than is required for receptor saturation
-EC50<Kd
-due to the fact that various signal transduction pathways activated by drugs allow for significant amplification of a relatively small signal |
|
|
Term
|
Definition
median effective dose to produce therapeutic response |
|
|
Term
|
Definition
median dose to produce toxic reponse |
|
|
Term
|
Definition
median dose to kill subjects |
|
|
Term
|
Definition
TD50/ED50
-the greater the therapeutic windo, the better margin of safety |
|
|
Term
|
Definition
LD1/ED99
the bigger the better |
|
|